The modified National Institutes of Health Stroke Scale: Its Time Has Come

被引:108
作者
Meyer, B. C. [1 ]
Lyden, P. D. [1 ]
机构
[1] UCSD, Dept Neurosci, Sch Med, OPC,Stroke Ctr, San Diego, CA 92103 USA
关键词
mNIHSS; modified; NIHSS; reliability; stroke scale; TISSUE-PLASMINOGEN ACTIVATOR; CANADIAN NEUROLOGICAL SCALE; ACUTE ISCHEMIC-STROKE; INTERRATER RELIABILITY; CLINICAL-TRIALS; RETROSPECTIVE ASSESSMENT; MEDICAL-RECORDS; TREATMENT TOAST; VALIDITY; TELEMEDICINE;
D O I
10.1111/j.1747-4949.2009.00294.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The National Institutes of Health Stroke Scale (NIHSS) is a well known, reliable and valid stroke deficit scale. The NIHSS is simple, quick, and has shown significant reliability in diverse groups, settings, and languages. The NIHSS also contains items with poor reliability and redundancy. Recent investigations (include assessing a new training DVD, analyzing webbased or videotape certifications, and testing foreign language versions) have further detailed reliability issues. Items recurrently shown to have poor reliability include Level of Consciousness, Facial Palsy, Limb Ataxia, and Dysarthria. The modified NIHSS (mNIHSS) minimizes redundancy and eliminates poorly reliable items. The mNIHSS shows greater reliability in multiple settings and cohorts, including scores abstracted from records, when used via telemedicine, and when used in clinical trials. In a validation of the mNIHSS against the NIHSS, the number of elements with excellent agreement increased from 54% to 71%, while poor agreement decreased from 12% to 5%. Overall, 45% of NIHSS items had less than excellent reliability vs. only 29% for the mNIHSS. The mNIHSS is not the ideal stroke scale, but it is a significant improvement over the NIHSS. The mNIHSS has shown reliability at bedside, with record abstraction, with telemedicine, and in clinical trials. Since the mNIHSS is more reliable, it may allow for improved practitioner communication, improved medical care, and refinement of trial enrollments. The mNIHSS should now serve as the primary stroke clinical deficit scale for clinical and research aims. When it comes to the mNIHSS, its time has come!.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 36 条
[1]   Baseline NIH Stroke Scale score strongly predicts outcome after stroke - A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) [J].
Adams, HP ;
Davis, PH ;
Leira, EC ;
Chang, KC ;
Bendixen, BH ;
Clarke, WR ;
Woolson, RF ;
Hansen, MD .
NEUROLOGY, 1999, 53 (01) :126-131
[2]   ENSURING RELIABILITY OF OUTCOME MEASURES IN MULTICENTER CLINICAL-TRIALS OF TREATMENTS FOR ACUTE ISCHEMIC STROKE - THE PROGRAM DEVELOPED FOR THE TRIAL OF ORG-10172 IN ACUTE STROKE TREATMENT (TOAST) [J].
ALBANESE, MA ;
CLARKE, WR ;
ADAMS, HP ;
WOOLSON, RF ;
BENDIXEN, BH ;
DAVIS, PH ;
JACOBY, MR ;
GOMEZ, FJ ;
DYKEN, ME ;
UC, EY ;
WOJCIESZEK, JM ;
KAPPELLE, LJ ;
TANNA, AB ;
MITCHELL, VL ;
GOMEZ, CR ;
MALKOFF, MD ;
TULYAPRONCHOTE, R ;
SAUER, CM ;
RIAZ, G ;
SCHMIDT, JG ;
MALIK, MM ;
BANET, GA ;
KARANJIA, PN ;
MADDEN, KP ;
RUGGLES, KH ;
MICKEL, SF ;
GOTTSCHALK, PG ;
HANSOTIA, PL ;
SORENSON, RW ;
JACOBSON, DM ;
HINER, BC ;
MANCL, K ;
LUKASIK, E ;
BRUNO, A ;
LAKIND, ED ;
JEFFREY, DR ;
MLADINICH, EK ;
IQBAL, J ;
REINERS, M ;
BARRETT, DW ;
SHIBUYA, D ;
WILLIAMS, JK ;
RUSSELL, P ;
KING, MK ;
CHAPIN, JE ;
CARTER, S ;
JEFFRIES, L ;
HIER, DB ;
SHAPIRO, RA ;
BRINT, SU .
STROKE, 1994, 25 (09) :1746-1751
[3]   CLINIMETRICS IN STROKE RESEARCH [J].
ASPLUND, K .
STROKE, 1987, 18 (02) :528-530
[4]   Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility [J].
Barber, PA ;
Zhang, J ;
Demchuk, AM ;
Hill, MD ;
Buchan, AM .
NEUROLOGY, 2001, 56 (08) :1015-1020
[5]   MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE [J].
BROTT, T ;
ADAMS, HP ;
OLINGER, CP ;
MARLER, JR ;
BARSAN, WG ;
BILLER, J ;
SPILKER, J ;
HOLLERAN, R ;
EBERLE, R ;
HERTZBERG, V ;
RORICK, M ;
MOOMAW, CJ ;
WALKER, M .
STROKE, 1989, 20 (07) :864-870
[6]   Retrospective assessment of initial stroke severity - Comparison of the NIH Stroke Scale and the Canadian Neurological Scale [J].
Bushnell, CD ;
Johnston, DCC ;
Goldstein, LB .
STROKE, 2001, 32 (03) :656-660
[7]   Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke [J].
Chalela, JA ;
Kasner, SE ;
Jauch, EC ;
Pancioli, AM .
STROKE, 1999, 30 (11) :2366-2368
[8]   THE CANADIAN NEUROLOGICAL SCALE - VALIDATION AND RELIABILITY ASSESSMENT [J].
COTE, R ;
BATTISTA, RN ;
WOLFSON, C ;
BOUCHER, J ;
ADAM, J ;
HACHINSKI, V .
NEUROLOGY, 1989, 39 (05) :638-643
[9]   A COMPARISON OF 5 STROKE SCALES WITH MEASURES OF DISABILITY, HANDICAP, AND QUALITY-OF-LIFE [J].
DEHAAN, R ;
HORN, J ;
LIMBURG, M ;
VANDERMEULEN, J ;
BOSSUYT, P .
STROKE, 1993, 24 (08) :1178-1181
[10]   Interrater reliability of the National Institutes of Health Stroke Scale: Rating by neurologists and nurses in a community-based stroke incidence study [J].
Dewey, HM ;
Donnan, GA ;
Freeman, EJ ;
Sharples, CM ;
Macdonell, RAL ;
McNeill, JJ ;
Thrift, AG .
CEREBROVASCULAR DISEASES, 1999, 9 (06) :323-327